Background. Delirium is common after surgery, although the aetiology is poorly defined. Brain-derived neurotrophic factor (BDNF) is a neurotrophin important in neurotransmission and neuroplasticity. Decreased levels of BDNF have been associated with poor cognitive outcomes, but few studies have characterized the role of BDNF perioperatively. We hypothesized that intraoperative decreases in BDNF levels are associated with postoperative delirium. Methods. Patients undergoing spine surgery were enrolled in a prospective cohort study. Plasma BDNF was collected at baseline and at least hourly intraoperatively. Delirium was assessed using rigorous methods, including the Confusion Assessment Method (CAM) and CAM for the intensive care unit. Associations of changes in BDNF and delirium were examined using regression models. Results. Postoperative delirium developed in 32 of 77 (42%) patients. The median baseline BDNF level was 7.6 ng ml À1 [interquartile
Delirium is characterized as an acute and fluctuating disturbance in cognition and attention that affects 15-53% of older adults after surgery. 1 Delirium is associated with functional decline, 2 cognitive dysfunction, 3 and increased mortality. 4 While the pathophysiology of delirium remains largely unknown, inflammation, neurotransmitter imbalance, and metabolic derangement have been proposed as mechanisms. 1 Older adults are most at risk for delirium, a concern given the increasing frequency of surgery in this population. In particular, spine surgery has become more common in older adults and ranks in the top five most frequent surgeries for adults 65-79 years old in the USA. We previously reported an incidence of delirium after spine surgery in older adults of 40%. 5 Importantly, some evidence suggests this condition is potentially preventable. 6 Given the prevalence and importance of delirium for patient outcomes, identifying high-risk patients and understanding the mechanisms of delirium are critically important. Brain-derived neurotrophic factor (BDNF) is a 13.5-kDa member of the neurotrophin protein family that influences neuroplasticity and neurotransmission and plays a key role in learning, memory, and cognition. 7 BDNF is abundant in the central nervous system. 8 It crosses the blood-brain barrier (BBB) and blood BDNF levels have been shown to correlate with both cerebrospinal fluid and brain BDNF levels. 9 10 Studies in community-dwelling populations 11 12 and traumatic brain injury (TBI) 13 14 show that decreased levels of BDNF are associated with poor cognitive outcomes. However, few studies have characterized BDNF in the perioperative period or investigated whether BDNF levels identify a risk for postoperative delirium. The objective of this exploratory study was to conduct a secondary analysis to characterize perioperative changes in BDNF levels in older adults undergoing spine surgery and to test the hypothesis that a decrease in intraoperative BDNF levels from baseline is associated with postoperative delirium.
Methods

Study overview
This prospective observational study was conducted at a single centre with approval from the Johns Hopkins Medical Institution Review Board and registered on ClinicalTrials.gov as NCT01574950. Patients provided written informed consent. Subjects were enrolled between February 2012 and July 2014. The primary aim of the study was to determine the association of impaired cerebral autoregulation 15 and postoperative delirium. Data from this cohort of subjects have been previously used to characterize the incidence and impact of delirium after spine surgery. 5 Inclusion criteria were age !70 years old and undergoing lumbar spine surgery, posterior cervical spine surgery, or anterior cervical spine surgery >2 levels. Exclusion criteria were baseline delirium, Mini Mental State Examination (MMSE) score <15, non-English speaking, severe hearing impairment, or planned use of ketamine or remifentanil, unless for airway management. Of the 89 subjects in this study reported on previously, 5 12 did not have intraoperative BDNF samples available, generally because an arterial catheter was not clinically indicated during the surgery, and thus frequent blood sampling was not feasible. This left a total of 77 subjects for inclusion in this analysis.
Perioperative clinical care
Subjects received standard intraoperative monitoring. Anaesthetic care generally consisted of propofol (induction), volatile anaesthetic (maintenance), fentanyl with or without hydromorphone (pain control), and a non-depolarizing muscle relaxant. Postoperatively, subjects typically received patientcontrolled analgesia (fentanyl or hydromorphone). With oral intake, subjects transitioned to oral opioids, typically oxycodone. Long-acting opioids were restarted if the subject was taking them at baseline.
BDNF measurement
Plasma BDNF was collected at baseline (shortly after anaesthetic induction and placement of an arterial catheter) and then at least hourly during surgery. Samples were collected into glass tubes containing ethylenediaminetetraacetic acid and processed within 3 h of collection. Samples were centrifuged at 3000 g for 8 min and plasma was removed and stored at À80 C until assay. Samples were assayed in batches as described 13 using an electrochemiluminescent sandwich immunoassay. They were read with a Sector Imager 2400 (Meso Scale Diagnostics, Rockville, MD USA). BDNF assay capture (MAB848), antibodies for detection (MAB648), and standards (248BD005) were purchased from R&D Systems (Duoset reagents, cat. #DY248; Minneapolis, MN, USA). These assays were carried out in one laboratory by staff blinded to outcomes. The lower limit of detection for the assay was 0.0125 ng mL
À1
. The plasma quantification lower limit was 0.15 ng mL À1 .
Delirium assessment
Delirium was assessed using rigorous methodologies, including the Confusion Assessment Method (CAM), 16 the CAM for the intensive care unit (CAM-ICU), 17 and a validated chart review method. 18 The CAM assessment was carried out by trained research staff and included a cognitive exam (digit span forwards and backwards, timed months of the year backwards, MMSE). Additionally, research staff asked the patient, nurses, families, and medical records for evidence of delirium-including confusion, agitation, sedation, hallucinations, and delusions-in the previous 24 h. Evidence from this overall assessment informed the CAM delirium diagnosis. For intubated non-verbal subjects in the ICU, the validated CAM-ICU was used. For subjects who could not be assessed in person due to either patient or staff availability, a validated chart review methodology was used (sensitivity 74% and specificity 83%), in accordance with prior methods. 18 For the chart review, a trained research assistant searched all sections of the electronic health record for evidence of delirium. Pertinent evidence was based on the question: 'Is there any evidence of acute confusional state (e.g. delirium, mental status change,
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inattention, disorientation, hallucinations, agitation, inappropriate behaviour)?' For each possible occurrence of delirium, staff recorded a verbatim description as well as the source of information and time of onset. An expert panel (C.B., L.M., K.N.) reviewed the abstractions and determined the final delirium diagnosis.
The once-daily delirium evaluations were only conducted on the first 4 postoperative days because evidence suggests that >90% of delirium occurs within this period. 19 In the overall cohort assessed for delirium, 70% of delirium assessments during the first 4 in-hospital postoperative days were in-person (CAM or CAM-ICU), while 30% used chart review. All patients eventually classified as delirious had at least one in-person CAM-positive assessment. To further classify delirium episodes, information from each assessment was used to evaluate delirium severity with the Delirium Rating Scale-Revised-98 (DRS-98-R). 20 The DRS-98-R is a 13-item clinician-rated severity scale, with scores ranging from 0 to 39. Items represent symptoms and are rated on a scale of 0-3 points using text descriptions. Items include sleep-wake cycle, hallucinations, delusions, affect, language, thought processes, motor agitation and retardation, orientation, attention, memory, and visuospatial ability. Several approaches were used for quality assurance of the delirium assessments. First, delirium assessors underwent formal training (including readings, videos, and delirium assessments of 10 subjects) with author K.N., an expert in delirium diagnosis. Ongoing quality assurance included co-ratings of subjects every 2 weeks and monthly meetings with delirium experts to discuss delirium assessments of non-study patients to ensure consistent methods and judgment.
Other data
Subjects were interviewed prior to surgery to obtain baseline information, including education and pain scores (0-10 scale). The MMSE was administered prior to surgery. Additional subject and perioperative information was obtained through interviews with subjects and through review of medical records.
Statistical analysis
This was a secondary analysis of data from a prospective observational study. Statistical analyses were carried out using SAS version 9.2 (SAS Institute, Cary, NC, USA) and the GPScore package in STATA version 12 (StataCorp, College Station, TX, USA). The original sample size was based on a separate primary hypothesis for which data are still being analysed (determining differences in mean arterial pressure at the lower limit of cerebral blood flow autoregulation among delirious compared with non-delirious patients). For analytic purposes, delirium was defined as any delirious episode after surgery as assessed by CAM, CAM-ICU, or chart review. Delirium severity was considered as the highest severity score.
Characteristics of the study population were compared using t-tests, rank-sum tests, v 2 tests, and Fisher's exact tests. We characterized BDNF decline as the percent BDNF decline [defined as 100Â(baselineÀlowest BDNF)/baseline BDNF], since this would avoid floor effects if baseline BDNF levels were low and also would account for the lowest BDNF level (not average decline). This was the primary exposure of interest. Logistic regression was used to examine the association between changes in BDNF and delirium, and median regression was used for the outcome of delirium severity. Covariates to include in adjusted models were chosen based on potential strong associations with delirium and included age, baseline MMSE score, and length of surgery.
We also examined a model that included age, ICU length of stay, and estimated blood loss as a post hoc analysis. We conducted several sensitivity analyses. First, since the most accurate approach to describe the decline in BDNF is unclear, we considered two other methods-absolute decline in BDNF (baseline BDNF levelÀlowest BDNF level), as well as the average slope of BDNF decline using mixed models. Second, we accounted for other potentially confounding variables using generalized propensity score analysis with continuous treatment, as described. 21 Variables used for propensity score analysis were chosen based on known associations with delirium and based on exploratory data analysis of variables associated with changes in BDNF.
Variables included in the propensity score analysis were age, gender, race, education, average pain, baseline MMSE, depression, smoking, alcohol, glasses, hearing aids, number of comorbidities, angiotensin-converting enzyme inhibitor use, length of surgery, number of levels, fusion, estimated blood loss, blood transfusion, i.v. fluid administered, and ICU length of stay. In an exploratory analysis we identified two outliers that were highly influential, and so conducted analyses with and without these points.
Results
Subject, surgical, and delirium characteristics
Seventy-seven subjects were included in this analysis, with a flow diagram presented in Supplementary Appendix A. Subject and surgical characteristics are shown in Table 1 . The median age was 75 years and 41 (53%) subjects were male. Subjects were relatively well educated, with a baseline median MMSE of 28.
Pain was a prominent complaint, with a median pain score of 6. The majority of surgeries (84%) involved the lumbar spine; the median number of levels was 4 and the average length of surgery was 317 (SD 128) min. Overall, 32 (42%) patients developed delirium, with a median number of days of delirium of 2 (IQR 1-2). The median delirium severity score for patients with delirium was 9 (IQR 8-15).
Changes in BDNF
At baseline, the median BDNF level was 7.6 ng ml À1 (IQR 3.0-11.2). During the course of surgery, individual trajectories of BDNF levels varied, as shown in Figure 1 , but the predominant pattern was a decline over time. The median BDNF decline was 61% (IQR 31-80). We also calculated the absolute decline in BDNF from baseline to the lowest value; the median absolute decline was 3.7 ng ml À1 (IQR 0.8-7.0). Finally, we calculated the average rate of BDNF decline using mixed model approaches, which was 0.62 ng ml À1 h À1 (0.70).
Subject and surgical characteristics by change in BDNF ratio are presented in Table 1 . Notably, patients with a decrease in BDNF ratio greater than the median were more likely to have had more extensive surgery, as indicated by greater i.v. fluid administered. Trends towards a longer length of surgery and more spinal levels involved were not significant.
Changes in intraoperative BDNF and postoperative delirium
There were no differences in median baseline BDNF levels between delirious [ Figure 2A . In multivariable-adjusted models (adjusted for age, baseline MMSE, and surgery length) and in propensity score-adjusted models, the association of percent BDNF decline from baseline and delirium remained similar (Tables 2 and 3 ). The results were also similar in a post hoc analysis with adjustment for age, ICU length of stay, and estimated blood loss [OR 1.02 (95% CI 1.00-1.03); P¼0.04].
We also considered several sensitivity analyses (Table 3 and Fig. 2) . First, we examined the association of delirium and two alternative ways of quantifying change in BDNF: absolute change of BDNF (defined as baselineÀlowest value) and average change of BDNF (defined by the average slope in mixed models). The absolute decline in BDNF levels was not statistically associated with increased odds of delirium in unadjusted models (P¼0.06), multivariable-adjusted models (P¼0.09), and propensity score-adjusted models (P¼0.06). There was also no association between the average change in BDNF (using mixed models) and postoperative delirium in any model ( Table 3) . As a final sensitivity analysis, we excluded two points that may be outliers and exerted substantial influence on the models (Figs 1 and 2 , highlighted by an arrow), but the inferences of the models were unchanged.
Changes in intraoperative BDNF and severity of postoperative delirium
Intraoperative decline in BDNF levels was also associated with delirium severity. As shown in Table 4 , in unadjusted models, each percent decline in BDNF from baseline was associated with a higher median delirium severity score [b coefficient 0.04 (95% CI 0.005-0.75), P¼0.03]. These results were similar for absolute change in BDNF and in multivariable-adjusted models, but not propensity score-adjusted models (Table 3) . On the other hand, there was no association between the slope of change in BDNF levels and delirium severity.
Discussion
In this secondary data analysis from a prospective cohort study, we report an association between intraoperative decline of plasma BDNF levels from baseline and increased incidence of postoperative delirium. Intraoperative BDNF decline was also associated with higher delirium severity scores. BDNF is critical for brain function, with the implication that understanding changes in circulating BDNF is important. In post-mortem human brain tissue, lower levels of BDNF have been reported in patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) 22 and depression and bipolar disorder. 23 In studies using human blood samples, decreased BDNF levels have been reported in major depression, 24 psychosis, 9 and schizophrenia. 25 Reduced serum BDNF levels have also been associated with poor cognition in the healthy elderly 12 and those with amnestic MCI 26 and
Alzheimer's disease, 11 27 although these results have not been consistent. 28 Outcome studies in patients with neurologic injury or critical illness also suggest an important role for BDNF. After TBI, BDNF levels are lower than in healthy controls. 13 14 Furthermore, lower levels of BDNF shortly after TBI are associated with more severe TBI symptoms and worse long-term outcomes. 13 In spite of a potential neuroprotective role of BDNF, perioperative changes in circulating BDNF have not been well characterized. Small studies have shown decreases in BDNF levels shortly after induction of anaesthesia, 29 30 however, the frequency of BDNF sampling was low, surgeries were short, and postoperative delirium was not assessed. Few studies have examined serum or plasma concentrations of BDNF in relation to delirium. In a comparison of BDNF levels in 30 delirious ICU patients and matched controls, 31 serum levels were significantly higher in those with delirium, but only 13% of the admissions were after surgery. Mean admission concentrations for both groups were lower than baseline levels in our study, potentially reflecting a different time point in the disease process. In a study of plasma BDNF levels after ICU admission, the mean BDNF level at 48 h was lower in non-survivors compared with survivors. Further, the BDNF level was correlated with delirium and coma-free days. 32 The precise mechanisms for our findings are unclear. Alterations in neurotransmitter signalling, including decreased cholinergic activity and increased dopaminergic activity, have been implicated in the development of delirium. 33 BDNF promotes the function and survival of cholinergic and dopaminergic neurons as well as augmentation of neurotransmission, 34 so altered neurotransmission due to low BDNF could play a role. BDNF is highly expressed in the prefrontal cortex and hippocampus, areas essential for memory function, cognition, and behaviour. 35 For example, BDNF facilitates working memory 36 and is essential for long-term memory. 37 Stress decreases brain BDNF messenger RNA synthesis, suggesting a mechanism for decreased BDNF levels during surgery. 38 Further investigations are needed to gauge the clinical importance of these findings. BDNF might be a biomarker for detecting individuals at risk for delirium and could lead to early prevention strategies. Since hypoactive delirium can be difficult to diagnose, this could aid early diagnosis and treatment. Similarly, strategies aimed at increasing BDNF levels, including administration of antidepressants, 39 cognitive rehabilitation, 40 and exercise, 41 could potentially be neuroprotective. It is noteworthy that exercise and mobility are important components of delirium-prevention strategies, and exercise greatly increases BDNF levels. Several limitations to this study should be considered in interpreting these results. This exploratory study involved a singlecentre, single-surgery procedure, had a small sample size, and was hypothesis generating. The delirium incidence was high, perhaps reflecting that many surgeries were multilevel with extensive blood loss. Our delirium-detection methodology is also sensitive and might detect delirium that would not be clinically apparent. We did not measure BDNF levels postoperatively; it would be informative to determine BDNF as delirium presents In summary, we show an association between decreases in BDNF levels intraoperatively and the incidence of postoperative delirium in older adults. These preliminary results need to be confirmed, but suggest that changes in plasma BDNF levels may provide a biomarker for postoperative delirium. These findings should be extended to examine changes in BDNF levels in different surgical populations and as a target for possible interventions to prevent delirium.
